Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history.

Fanouriakis, Antonis

Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history. [electronic resource] - Seminars in arthritis and rheumatism Jun 2014 - 751-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1532-866X

10.1016/j.semarthrit.2013.11.007 doi


Adrenal Cortex Hormones--therapeutic use
Adult
Antibodies, Monoclonal, Humanized--therapeutic use
Antibodies, Monoclonal, Murine-Derived--therapeutic use
Antirheumatic Agents--therapeutic use
Azathioprine--therapeutic use
Comorbidity
Female
Glatiramer Acetate
Greece--epidemiology
Humans
Hydroxychloroquine--therapeutic use
Immunologic Factors--therapeutic use
Immunosuppressive Agents--therapeutic use
Interferon-beta--therapeutic use
Lupus Erythematosus, Systemic--drug therapy
Male
Methotrexate--therapeutic use
Middle Aged
Multiple Sclerosis--drug therapy
Natalizumab
Peptides--therapeutic use
Prevalence
Rituximab